Real Training Logs · Not Medical Advice · Check With Your Doctor Before Changing Your Exercise · Editorial Policy

GLP-1 Users Move Less: What the ENDO 2026 Study Means for Runners on Weight-Loss Drugs

Yes, GLP-1 users moved less after starting treatment in the ENDO 2026 study. Runners on weight-loss drugs should not expect lighter weight to bring more movement on its own. GLP-1 receptor agonists are prescription drugs that curb appetite and lower weight. The Chicago presentation followed 1,950 adults with obesity before and after they started drugs in this group, including semaglutide, liraglutide, dulaglutide and tirzepatide.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What did the ENDO 2026 study measure?

Researchers linked clinic records with Fitbit data from the same patients in the NIH All of Us Research Program. They compared daily activity before GLP-1 initiation with activity after initiation. Only 753 people, or 38.6%, had enough Fitbit data for analysis.

According to Healio, the group averaged 52.7 years old and 78.6% were women Healio report on SAT-714. According to the Endocrine Society, average steps fell from 5,047 to 4,487 per day, a drop of about 560 steps Endocrine Society release. HealthDay reported moderate-to-vigorous activity fell from about 27.9 to 22.2 minutes per day HealthDay summary.

Who slowed down the most?

Declines were largest in men and in people with joint or muscle pain. Age, heart failure and prior stroke did not change the pattern.

For runners, that pain link matters. Sore knees, hips or calves can quietly cut daily steps even when planned runs stay on the calendar.

Why does less movement matter for runners?

Lead researcher Sajana Maharjan warned that GLP-1s cut both fat and lean muscle. Activity protects strength and helps sustain weight loss over time.

Less muscle means less power for hills, less control late in runs and slower recovery. Weight loss alone does not preserve the leg strength running needs.

How can runners protect mileage and muscle?

Do not assume weight loss will make you more active. Protect running and strength work by design while appetite and weight change. Keep the next strength session booked before easier body weight makes running feel deceptively easy.

  • Keep regular runs scheduled through dose changes
  • Keep 2-3 resistance sessions each week for legs, hips and trunk
  • Pair training with enough protein to support muscle
  • Watch daily steps, not just workouts, for quiet drops

You Might Also Like

1 thought on “GLP-1 Users Move Less: What the ENDO 2026 Study Means for Runners on Weight-Loss Drugs”

Comments are closed.

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.